supplementhackr
Performix

Super Male T

Serving
3 Capsule(s)
Per container
26
Form
capsule-unknown
UPC
811274024711
DSLD
308939
Formula hash
9db808847ca4
Brand context
Performix
Catalog
49
products
With avoid flag
12
products
FDA recalls
0
history
CAERS
14
reports
Avoid-flaggedObjective label signals
Flagged excipients
3
1 avoid · 2 caution
FDA recalls
0
no recall history
CAERS reports
4
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

6 active ingredients
IngredientAmount% DV
Calories
otherUNII · 1
5 Calorie(s)—
Total Carbohydrates
CarbohydrateotherUNII · 0
1 Gram(s)1%
Vitamin D
vitaminUNII · 9VU1KI44GP
UL · set4 effects
37.5 mcg188%
Vitamin B6
vitaminUNII · KV2JZ1BI6Z
UL · set6 effects
7.5 mg441%
Zinc
mineralUNII · J41CSQ7QDS
UL · set8 effects
30 mg273%
Performance Matrix
Blendother
669 mg—
What this product supports · authorized claims

15 authority-backed effects

Rolled up from EFSA / FDA / NIH ODS authorized function claims on this product's active ingredients. Each row shows which ingredients contribute.

Flagged excipients

3 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

    eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
  • ◐ CAUTIONFD&C Red #40 Lake
    color

    EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).

    eur-lex.europa.eu →leginfo.legislature.ca.gov →
  • ◐ CAUTIONFD&C Yellow #5 Lake
    color

    EU requires warning label 'may have an adverse effect on activity and attention in children' per Commission Regulation 1333/2008 Annex III (following Southampton study 2007). FDA requires specific label declaration (21 CFR 74.705).

    eur-lex.europa.eu →ecfr.gov →
FDA CAERS · adverse event context
4
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Sucrose · Gelatin · Starch · Rice Flour · Polyvinylpyrrolidone · Maltodextrin · Pharmaceutical Glaze · Sodium Ascorbate · Triglycerides · Silicon Dioxide · Vanilla Flavor, Natural · Tocopherols